Corporate Moves & Markets: Curaleaf launched a hostile takeover bid for Aurora Cannabis, offering $4 per share (cash + stock) and pitching a 45% premium, while Aurora responded to the move and trading activity around ACB spiked. Clinical & Public Health: A CDC report found ED visits tied to cannabis hyperemesis syndrome jumped after a new CHS ICD-10 code went live in Oct. 2025, suggesting the condition was previously undercounted and emergency staff need better recognition. Research Watch: Lab work in glioblastoma models suggests some cannabinoids (including CBD and CBGV) may blunt chemotherapy/radiation-induced cell death, raising new questions for cancer research. Policy & Compliance: Texas’ hemp-derived THC ban survived an emergency court challenge for now, keeping delta-8 and other non-delta-9 hemp THCs classified as controlled. Local Industry Pressure: Michigan’s 24% wholesale cannabis tax is squeezing dispensaries in the U.P., with some closures tied directly to the added cost. Retail & Community: New Jersey’s Noiré Dispensary is leaning into rotating menus plus delivery, while New York’s The Artist Tree is expanding with an art-forward dispensary concept. Enforcement & Safety: Police raids and seizures continued across regions, including illegal cannabis operations in California and contraband busts involving cannabis and other drugs. Food & Farming Risk: Edo State’s NDLEA warned cannabis cultivation is pulling farmers away from food production, raising fears of shortages. Housing & Homelessness: Wellington’s Downtown Community Ministry is fundraising for emergency shelter as rough sleeping rises and motel placements become a stopgap.